Finanzwire Finanzwire
Basculer en Français
10900 Companies
237521 Keywords
166440 Articles
127566 Press releases
Headlines Articles Press releases Clairvoyant Therapeutics Remove
  1. Home
  2. Companies
  3. Clairvoyant Therapeutics
Finanzwire
Basculer en Français
Headlines Articles Press releases

News

  • BRIEF

    published on 04/03/2024 at 14:05, 2 years 4 months ago

    Clairvoyant Therapeutics Advances Psilocybin Clinical Trial for Alcohol Use Disorder

    Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder Regulatory Pathway
  • PRESS RELEASE

    published on 04/03/2024 at 14:00, 2 years 4 months ago

    Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization

    Clairvoyant Therapeutics aims to commercialize psilocybin treatment for alcohol use disorder by 2025. Company's trial progressing well, expecting results in 2024 & financing round underway
    Commercialization Clinical Trial Clairvoyant Therapeutics Psilocybin Treatment Alcohol Use Disorder
    Logo of Clairvoyant Therapeutics
  • PRESS RELEASE

    published on 11/29/2023 at 13:00, 2 years 9 months ago

    Clairvoyant Surpasses 50 Per Cent Randomization in its Phase 2b Psilocybin Therapy Trial for Alcohol Use Disorder

    Logo of Clairvoyant Therapeutics
  • PRESS RELEASE

    published on 03/20/2023 at 12:00, 3 years 5 months ago

    First Patient Dosed in Europe in Clairvoyant’s Phase 2b Clinical Trial Exploring Psilocybin Therapy as a Treatment for Alcohol Use Disorder

    Logo of Clairvoyant Therapeutics
Accesswire
  • Published on 08/31/2026 at 13:30, 52 minutes ago

    Nextech3D.ai Delivers 101% Revenue Growth in Fiscal Q1 2027 as AI-Powered Event Platform Accelerates

  • Published on 08/31/2026 at 13:30, 52 minutes ago

    Condor Receives Environmental Permit (DIA) for Drilling at Flagship Pucamayo Project

  • Published on 08/31/2026 at 13:00, 1 hour 22 minutes ago

    CoTec Provides Update on Commercial Deployment of Multi-Gravity Separator Technology

  • Published on 08/31/2026 at 13:00, 1 hour 22 minutes ago

    ATHA Energy Provides Board of Directors Update

  • Published on 08/31/2026 at 12:45, 1 hour 37 minutes ago

    Northern Dynasty Minerals Reports Change to Board of Directors

View all ACCESSWIRE
EQS Group
  • Published on 08/31/2026 at 13:55, 27 minutes ago

    Amundi Physical Metals plc: UK Final Terms

  • Published on 08/31/2026 at 13:31, 51 minutes ago

    Amundi Physical Metals plc: Final Terms

  • Published on 08/31/2026 at 12:47, 1 hour 35 minutes ago

    hep global successfully develops two solar projects with battery storage systems west of Munich

  • Published on 08/31/2026 at 12:45, 1 hour 37 minutes ago

    TCL Powers the Tides of Annihilation Experience at Gamescom 2026 with Advanced Display Technology

  • Published on 08/31/2026 at 10:35, 3 hours 47 minutes ago

    Deufol SE publishes two key reports: the half-year report 2026 with the operational figures for the first half of the year and the second voluntary sustainability report for the 2025 financial year.

View all EQS
Les Echos
  • Published on 08/31/2026 at 12:00, 2 hours 22 minutes ago

    Capital increase through exercise of subscription rights

  • Published on 08/31/2026 at 07:00, 7 hours 22 minutes ago

    Biophytis strengthens its financial position and extends its cash runway into Q1 2027

  • Published on 08/28/2026 at 06:55, 3 days 7 hours ago

    Recticel Accelerates Profitable Growth

  • Published on 08/26/2026 at 18:02, 4 days 20 hours ago

    Altareit: Altarea press release regarding the Primonial matter

  • Published on 08/26/2026 at 18:00, 4 days 20 hours ago

    Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)

View all LES ECHOS COMFI WIRE

With finanzwire.com, you can follow all the latest financial news in real time from the best sources for companies listed on the Paris, Brussels, Amsterdam, Lisbon, Frankfurt and New York stock exchanges. You'll have access to summary articles written by us and press releases published by the companies themselves.

Finanzwire

87, rue Ordener - 75018 Paris

Contact us

+33 1 42 23 83 61

© 2026 Finanzwire

Contact Authors Cookies policy Terms and conditions Privacy policy